Med BioGene Announces Date of Annual and Special Meeting and Adoption of Shareholder Rights Plan
1/20/2010 11:19:22 AM
More...
|
Med BioGene Files Registration Statement for Proposed $24.25M U.S. IPO
12/30/2009 7:09:04 AM
More...
|
Med BioGene Announces Poster Presentations of LungExpress Dx Validation Study and Health Economics Evaluation at AACR-IASLC Meeting in January
12/3/2009 10:09:41 AM
More...
|
Med BioGene Announces Positive Results From Validation Study of LungExpress DX(TM)
10/15/2009 9:22:36 AM
More...
|
Med BioGene Closes Final Tranche of Private Placement
10/8/2009 10:09:59 AM
More...
|
Med BioGene Reports Financial Results for the Second Quarter of 2009
8/18/2009 11:02:56 AM
More...
|
Med BioGene Broadens Commercialization Team to Oversee Launch Preparations for LungExpress DxTM Gene Expression Test
10/23/2008 10:02:33 AM
More...
|
Med BioGene Reports Financial Results for the Second Quarter 2008
9/9/2008 2:59:12 PM
More...
|
Med BioGene Announces Financing
7/14/2008 10:51:22 AM
More...
|
Med BioGene Expands Lymphoma Collaboration; Becomes Founding Corporate Collaborator of Translational Working Group in Hematologic Malignancies
6/17/2008 3:25:43 PM
More...
|
|